онкологические заболеваниянейропатическая больпротивоопухолевая терапия1.Брюзгин В.В. Хронический болевой синдром у онкологических больных (организационно - методические аспекты). Дис.. докт. мед. наук. М., 1993.2.Дунаевский И.В. Лечение хронического болевого синдрома у онкологических больных. Материалы III ежегодной Российской онкологической конференции НИИ онкологии им. проф. Н.Н.Петрова. Спб., 1999.3.Новиков Г.А. Основы паллиативной помощи онкологическим больным с хронической болью. Дис.. докт. мед. наук. М., 1994.4.Осипова Н.А., Новиков Г.А., Прохоров Б.М. Хронический болевой синдром в онкологии. М.: Медицина, 1998.5.Elliott A, Smith B, Penny K et al. The epidemiology of chronic pain in the community. Lancet 1999;354 (9186): 1248–52.6.Pain in patients with cancer: Still a long to go. Pain 2007; 132 (3): 229–30.7.Wold Helth Organization. Cancer pain relief and palliative care/Report of a World Expert Committee. Geneva, WHO, 1990.8.Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 20079.McMahon S.B., Koltzenburg M. Wall and Melzack’s Textbook of pain. 5-th ed. Elsevier Churchill Livingstone, 2006.10.Fisch M.J., Burton A.W. Cancer Pain Management. The McGraw-Hill C, 2006.11.Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–69.12.Campbell J.N., Basbaum A.I., Dray A et al. Emerging Strategies for the treatment of Neuropathic Pain. Seattle. IASP Press, 2006.13.Fallon M. The Current Situation with Cancer Pain. Douglas M. Justins, IASP Press 2005; 165–9.14.Katherine E. Galluzzi D.O. Managing Neuropathic Pain. JAOA 2007; 107 (6): 39–48.15.Oscar A.L.C. Cancer Pain: pharmacologic, interventional, and palliative approaches. Saunders Elsevier. Philadelphia. USA, 2006.16.Stute P, Soukup, Menzel M. Analisis and treatment of different types of neuropatic cancer pain. J Pain Symptom Manage 2003; 26: 1123–30.17.Абузарова Г.Р., Осипова Н.А. Нейропатическая боль в онкологии: механизмы возникновения и современные подходы к лечению. Анестезиол. и реаниматол. 2005; 5: 33–9.18.Kloke M, Griseler N, Hense J, Kloke O. Effectiveness of Gabapentin in the therapy of neuropathic cancer pain: Results of a retrospective analysis [Ger with Eng abstr]. 2003; 24 (2): 57–63.19.Данилов А.Б. Габапентин (нейронтин) в лечении нейропатической боли. Клин. фармакол. и тер. 2004; 13 (4): 57–60.20.Berger A.M., Shuster J.L., Von Roenn Jr.J.H. Principles and practice of palliative care and support - ive oncology. 3d ed. Lippincott Williams&Wilkins, 2006.21.Caraceni A, Zecca E, Bonezzi C et al. Gabapentin of Neuropathic Cancer Pain: A Randomized Controlled Trial From the Gabapentin Cancer Pain Study Group. J Clin Oncology 2004; 22 (14): 2909–17.22.Lesser H, Sharma U, La Moreaux L, Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004; 63 (11): 2104–10.23.Zareba G. Pregabalin: A new agent for the treatment of neuropathic pain. Drugs Today 2005;(8).24.Dworkin R.H., Corbin A.E., Young J.P.Jr. et al. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo - controlled trial. Neurology 2003; 60: 1274–83.25.Siddall P.J., Cousins M.J., Otte A et al. Pregabalin in central naturopathic pain associated with spinal cord injury: a placebo - controlled trial. Neurology 2006; 67 (10): 1792–800.26.Attal N Experimental Studies of Potential Analgesics for the Treatment of Chemotherapy- Evoked Painful Peripheral Neuropathies/Inserm Boulogne-Billancourt, France. 2008.27.Levien T.L. Summary of new drug applications and biologic license applications submitted to the Food and Drug Administration: Pregabalin-Pfizer. Adv Pharmacy 2004; 2 (2): 185–6.28.Wesche D, Bockbrader H. A pharmacokinetic comparison of pregabalin and gabapentin. http://www.ampainsoc.org/abstract/2005/data/684/index.html